Bio-Rad Laboratories, Inc. Financial Ratios — BIO Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	14.09	11.46	4.96	5.38	6.24	1.43	6.68	13.17	38.26	51.76	37.33	-30.97	-6.65	-22.12	9.75
Return on Assets (%)	5.81	5.06	2.28	2.64	3.1	0.69	3.01	7.4	25.83	36.36	27.65	-23.18	-4.94	-17.03	7.62
Return on Capital (%)	10.27	9.28	5.58	4.97	5.74	1.8	- -	11.91	34.56	49.07	36.62	- -	- -	- -	8.69
Return on Invested Capital (%)	8.79	7.24	4.36	3.86	4.49	2.48	- -	3.43	3.27	3.95	3.24	- -	- -	- -	1.98
Gross Margin (%)	56.85	55.83	55.26	54.18	55.54	55.05	54.98	53.43	54.38	56.48	56.05	55.93	53.42	53.73	51.87
EBITDA Margin (%)	20.56	19.07	14.85	13.79	14.78	12.62	12.94	14.3	15.74	22	21.83	21.85	18.11	16.39	14.87
Operating Margin (%)	14.72	12.77	7.95	6.9	8.26	5.71	6.05	8.26	9.93	16.55	17.12	16.95	12.65	10.48	8.46
Incremental Operating Margin (%)	14.5	956.33	-149.26	-45.98	-10.75	-99.91	13.84	45.19	182.02	81.92	20.96	20.97	104.81	65.71	-301.8
Pretax Margin (%)	11.86	11.11	5.27	6.05	7.22	2.01	4.53	22.39	97.81	193.19	186.45	-167.88	-31.82	-91.27	38.54
Profit Margin (%)	8.63	8	3.65	4.08	5.41	1.26	5.66	15.97	76.08	149.83	145.57	-129.45	-23.86	-71.86	29.42
Net Income to Common Margin (%)	8.63	8	3.65	4.08	5.41	1.26	5.66	15.97	76.08	149.83	145.57	-129.45	-23.86	-71.86	29.42
Effective Tax Rate (%)	27.27	27.99	30.76	32.47	25.1	37.44	- -	28.68	22.22	22.44	21.93	- -	- -	- -	23.67
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	14.09	11.46	4.96	5.38	6.24	1.43	6.68	13.17	38.26	51.76	37.33	-30.97	-6.65	-22.12	9.75

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	733	734	437	436	434	435	435	439	651	226	223	1,388	1,406	1,375	1,386
ST Debt	1	2	2	- -	- -	- -	- -	- -	462	38	37	37	41	43	37
LT Debt	732	732	436	436	434	434	435	439	190	187	186	1,351	1,365	1,332	1,349
Total Debt/EBITDA	1.72	1.86	1.38	1.45	1.45	1.67	1.56	1.34	1.79	0.4	0.35	2.27	2.91	3.27	3.61
Net Debt/EBITDA	0.37	0.69	0.33	0.08	-0.08	-0.08	0.18	0.02	-0.64	-1.18	-0.72	1.25	1.65	1.7	1.76
Total Debt/EBIT	2.4	2.78	2.58	2.91	2.6	3.68	3.33	2.32	2.84	0.54	0.45	2.92	4.16	5.11	6.34
Net Debt/EBIT	0.52	1.02	0.62	0.15	-0.14	-0.18	0.39	0.04	-1.01	-1.57	-0.92	1.61	2.36	2.65	3.09
EBITDA to Interest Expense	8.02	7.72	5.17	13.55	13.76	11.16	12.14	13.66	15.54	25.61	411.31	16.07	9.79	8.6	7.84
EBITDA-CapEx/Interest Expense	8.01	7.69	5.16	12.85	13.7	11.15	11.98	13.66	11.33	20.65	325.07	13.07	6.62	4.74	4.62
EBIT to Interest Expense	5.74	5.17	2.77	6.78	7.69	5.05	5.68	7.89	9.81	19.27	322.59	12.47	6.84	5.5	4.46
Interest Expense	53	51	61	22	22	23	23	24	23	22	2	38	49	49	49
Common Equity/Total Assets	43.91	44.38	47.4	50.73	48.74	47.49	42.84	66.33	68.31	71.44	75.99	73.31	75.29	79.2	77.31
Long-Term Debt/Equity (%)	41.95	36.34	19.92	19.94	17.42	16.83	14.83	10.92	3.29	1.9	1.36	14.05	15.61	20.27	18.09
Long-Term Debt/Capital (%)	34.96	32.36	21.32	20.45	19.35	19.19	19.18	10.55	3.1	1.97	1.36	11.97	12.79	15.15	14.1
Long-Term Debt/Total Assets (%)	23.63	21.27	12.85	13.04	11.7	11.28	10.17	7.82	2.37	1.44	1.05	10.01	11.1	14.22	12.75
Total Debt/Equity (%)	41.99	36.43	20	19.95	17.43	16.85	14.85	10.93	11.31	2.28	1.63	14.44	16.08	20.93	18.6
Total Debt/Capital (%)	35	32.44	21.4	20.46	19.36	19.2	19.2	10.56	10.64	2.38	1.62	12.3	13.18	15.64	14.5
Total Debt/Total Assets (%)	23.65	21.32	12.91	13.05	11.7	11.28	10.18	7.83	8.13	1.74	1.25	10.28	11.43	14.68	13.11
Net Debt to Equity	9.07	13.43	4.84	1.04	-0.94	-0.84	1.75	0.2	-4.04	-6.68	-3.36	7.95	9.1	10.86	9.05
Net Debt/Capital (%)	10.42	15.05	6.18	1.32	-1.31	-1.2	2.72	0.21	-4.26	-7.47	-3.46	7.04	7.75	8.59	7.47
EBITDA	426	395	317	300	299	261	279	327	364	560	638	612	484	421	384
EBITDA-CapEx	426	393	316	284	297	261	276	327	265	451	504	498	327	232	226
Operating Income (Loss)	305	264	169	150	167	118	131	189	230	421	500	475	338	269	219

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.77	1.95	1.25	1.56	1.78	1.78	1.5	1.87	1.23	1.57	1.28	3.15	3.07	3.56	2.98
Current Ratio	3.92	4.1	3.61	3.84	4.03	3.91	3.93	4.49	2.41	3.39	2.92	5.55	5.83	6.48	5.62
Quick Ratio	2.64	2.79	2.12	2.41	2.67	2.57	2.43	2.74	1.66	2.23	1.9	4.02	4.01	4.53	3.87
CFO/Avg Current Liab	0.47	0.57	0.35	0.59	0.42	0.47	0.21	0.6	0.68	0.76	1.02	0.31	0.69	0.92	1.08
Common Equity/Total Assets	43.91	44.38	47.4	50.73	48.74	47.49	42.84	66.33	68.31	71.44	75.99	73.31	75.29	79.2	77.31
Long-Term Debt/Equity (%)	41.95	36.34	19.92	19.94	17.42	16.83	14.83	10.92	3.29	1.9	1.36	14.05	15.61	20.27	18.09
Long-Term Debt/Capital (%)	34.96	32.36	21.32	20.45	19.35	19.19	19.18	10.55	3.1	1.97	1.36	11.97	12.79	15.15	14.1
Long-Term Debt/Total Assets (%)	23.63	21.27	12.85	13.04	11.7	11.28	10.17	7.82	2.37	1.44	1.05	10.01	11.1	14.22	12.75
Total Debt/Equity (%)	41.99	36.43	20	19.95	17.43	16.85	14.85	10.93	11.31	2.28	1.63	14.44	16.08	20.93	18.6
Total Debt/Capital (%)	35	32.44	21.4	20.46	19.36	19.2	19.2	10.56	10.64	2.38	1.62	12.3	13.18	15.64	14.5
Total Debt/Total Assets (%)	23.65	21.32	12.91	13.05	11.7	11.28	10.18	7.83	8.13	1.74	1.25	10.28	11.43	14.68	13.11
CFO/Total Liabilities	19.43	18.66	14.07	23.64	15.27	17	7.76	17.95	20.32	18.91	16.27	5	10.54	16.29	17.04
CFO/CapEx	602.6	149.71	241.62	17.66	135.72	1,600.49	27.44	95,164.67	4.65	5.39	5.01	1.7	2.39	2.41	3.38
Altman's Z-Score	3.98	3.79	4.25	4.35	4.23	4.61	5.09	4.52	4.55	4.87	4.75	3.61	3.3	3.94	3.38

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	5.27	5.19	5.19	5.44	5.25	5.42	5.16	5.34	5.89	6.27	6.93	6.1	5.43	5.45	5.66
Days Sales Outstanding	69.24	70.33	70.29	67.15	69.51	67.4	70.73	68.34	61.98	58.22	52.64	59.8	67.2	66.95	64.51
Inventory Turnover	2.15	2.06	1.96	2.02	1.87	1.83	1.74	1.81	1.85	1.88	2.15	1.91	1.66	1.54	1.66
Days Inventory Outstanding	169.63	177.42	185.78	180.8	195.4	199.27	210.15	201.73	196.89	193.79	169.72	190.87	219.98	236.73	220.28
Accounts Payable Turnover	7.67	7.2	7.27	6.87	7.31	7.55	7.77	8.19	8.93	9.54	8.77	9.98	9.34	8.75	9.74
Accounts Payable Turnover Days	47.59	50.71	50.22	53.16	49.95	48.35	46.98	44.56	40.86	38.25	41.6	36.58	39.09	41.74	37.47
Cash Conversion Cycle	191.27	197.04	205.85	194.79	214.95	218.33	233.9	225.51	218.01	213.76	180.76	214.09	248.09	261.94	247.32
Inventory to Cash Days	-100.39	-107.09	-115.49	-113.65	-125.89	-131.87	-139.42	-133.39	-134.91	-135.57	-117.08	-131.07	-152.77	-169.78	-155.77
Inventories	434	455	516	471	490	525	595	584	554	622	572	719	780	760	741
Raw Materials	99	93	106	106	110	117	114	108	110	127	117	229	232	222	212
Work In Process	120	125	130	132	114	126	143	145	146	152	198	221	246	243	235
Finished Goods	214	237	281	233	266	282	338	331	298	343	257	270	303	295	293
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	2,692	2,972	3,534	3,481	4,047	5,366	7,078	6,929	11,043	17,353	22,539	12,524	9,431	9,269	8,260
- Cash & Cash Equivalents	574	463	332	413	458	456	384	432	661	662	471	434	404	488	530
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	733	734	437	436	434	435	435	439	651	226	223	1,388	1,406	1,375	1,386
Enterprise Value	2,612	2,785	3,362	3,220	3,695	4,961	6,758	6,523	10,579	16,588	21,893	12,122	9,230	8,979	8,106
Total Capital	2,093	2,263	2,044	2,131	2,242	2,263	2,265	4,162	6,122	9,494	13,749	11,286	10,666	8,791	9,562
Total Debt/Capital (%)	35	32.44	21.4	20.46	19.36	19.2	19.2	10.56	10.64	2.38	1.62	12.3	13.18	15.64	14.5
Total Debt / EV	0.28	0.26	0.13	0.14	0.12	0.09	0.06	0.07	0.06	0.01	0.01	0.11	0.15	0.15	0.17
EV/Sales	1.26	1.35	1.58	1.48	1.83	2.4	3.13	2.85	4.58	6.52	7.49	4.33	3.46	3.5	3.14
EV/EBITDA	6.13	7.06	10.62	10.74	12.38	19.01	24.18	19.93	29.08	29.62	34.32	19.79	19.08	21.35	21.11
EV/EBIT	8.56	10.54	19.84	21.47	22.16	42.04	51.68	34.48	46.07	39.37	43.76	25.51	27.32	33.38	37.08
EV/Cash Flow to Firm	8.67	9.18	15.89	11.17	18.25	21.51	50.85	21.56	22.22	27.56	32.64	54.17	22.41	18.19	14.23
EV/Free Cash Flow to Firm	8.65	9.13	15.84	10.6	18.13	21.49	49.44	21.56	18.41	23.35	27.22	35.85	16.23	13.15	11.15
Diluted Market Cap	2,734	3,009	3,573	3,512	4,078	5,404	7,168	7,020	11,169	17,581	22,824	12,524	9,431	9,269	8,266
Diluted Enterprise Value	2,893	3,280	3,679	3,535	4,054	5,382	7,219	7,027	11,159	17,145	22,577	13,478	10,433	10,155	9,122
EV per Share	93.18	98.46	117.61	111.5	126.6	168.53	227.88	218.63	354.5	557.23	733.9	406.97	315.99	318.24	297.32
TTM Sales	2,074	2,069	2,133	2,175	2,019	2,068	2,160	2,289	2,312	2,546	2,923	2,802	2,671	2,566	2,583
TTM EBITDA	426	395	317	300	299	261	279	327	364	560	638	612	484	421	384
TTM Operating Income	305	264	169	150	167	118	131	189	230	421	500	475	338	269	219
TTM Cash Flow to Firm	301	303	212	288	202	231	133	303	476	602	671	224	412	494	570
TTM Free Cash Flow to Firm	302	305	212	304	204	231	137	303	575	710	804	338	569	683	727

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	10.39	11.22	21.04	12.16	21.74	24.99	66.41	24.59	20.07	25.35	28.42	40.57	17.74	14.39	11.98
EV/EBIT	8.56	10.54	19.84	21.47	22.16	42.04	51.68	34.48	46.07	39.37	43.76	25.51	27.32	33.38	37.08
Enterprise Value	2,612	2,785	3,362	3,220	3,695	4,961	6,758	6,523	10,579	16,588	21,893	12,122	9,230	8,979	8,106
Low Price	84.02	91.52	106.1	102.71	112.51	122.03	181.87	220.05	223.89	309.38	545	344.63	261.59	262.12	211.43
EV/Sales	1.26	1.35	1.58	1.48	1.83	2.4	3.13	2.85	4.58	6.52	7.49	4.33	3.46	3.5	3.14
EV/EBITDA	6.13	7.06	10.62	10.74	12.38	19.01	24.18	19.93	29.08	29.62	34.32	19.79	19.08	21.35	21.11
Price/Earnings	15.04	17.96	45.42	39.18	37.05	206.4	57.9	18.95	6.28	4.55	5.3	- -	- -	- -	10.87
Price/Earnings Average	16.91	17.56	43.61	39.29	36.74	168.91	53.26	22.65	5.3	3.69	4.74	-4.15	-18.02	-4.88	10.06
Price/Earnings High	19.88	20.17	46.73	43.59	40.71	209.35	66.44	28.17	6.39	5.06	5.84	-6.18	-23.36	-5.94	13.41
Price/Earnings Low	13.16	15.65	38.99	33.38	30.06	138.18	44.12	17.96	3.8	2.41	3.82	-2.83	-11.99	-4.01	7.59
Price/Book Value	1.98	1.94	2.2	2.05	2.24	2.93	3.87	1.86	2.02	1.87	1.67	1.27	1.02	1.25	1.01
Price/Book Value Average	2.23	1.9	2.11	2.06	2.22	2.4	3.56	2.22	1.71	1.52	1.49	1.52	1.24	1.21	0.93
Price/Book Value High	2.62	2.18	2.26	2.29	2.46	2.98	4.44	2.77	2.05	2.08	1.84	2.26	1.61	1.48	1.25
Price/Book Value Low	1.73	1.69	1.89	1.75	1.82	1.96	2.95	1.76	1.22	0.99	1.2	1.04	0.83	1	0.7
Price/Tangible Book Value	2.65	2.36	2.52	2.43	2.27	2.77	3.15	1.89	2.07	1.85	1.72	1.41	1.18	1.58	1.23
Price/Tangible Book Value Average	2.98	2.31	2.42	2.44	2.25	2.26	2.89	2.26	1.75	1.5	1.54	1.7	1.43	1.54	1.14
Price/Tangible Book Value High	3.5	2.65	2.59	2.71	2.5	2.81	3.61	2.81	2.1	2.06	1.9	2.52	1.86	1.87	1.52
Price/Tangible Book Value Low	2.32	2.06	2.16	2.07	1.84	1.85	2.4	1.79	1.25	0.98	1.24	1.16	0.95	1.26	0.86
Price/Sales	1.3	1.44	1.66	1.6	2	2.59	3.28	3.03	4.78	6.82	7.71	4.47	3.53	3.61	3.2
Price/Sales Average	1.46	1.4	1.59	1.6	1.99	2.12	3.01	3.62	4.04	5.52	6.9	5.38	4.3	3.51	2.96
Price/Sales High	1.72	1.61	1.7	1.78	2.2	2.63	3.76	4.5	4.86	7.58	8.5	7.99	5.57	4.27	3.94
Price/Sales Low	1.14	1.25	1.42	1.36	1.63	1.74	2.5	2.87	2.89	3.62	5.56	3.66	2.86	2.88	2.23
Price/Cash Flow	10.25	11.15	20.89	12.74	21.73	24.84	67.97	24.27	24.12	29.66	33.67	64.43	25.16	20.36	15.52
Price/Cash Flow Average	11.52	10.91	20.06	12.77	21.56	20.32	62.53	29	20.37	24.03	30.11	77.52	30.64	19.78	14.36
Price/Cash Flow High	13.55	12.53	21.49	14.17	23.88	25.19	77.99	36.07	24.53	33	37.1	115.24	39.71	24.05	19.14
Price/Cash Flow Low	8.96	9.72	17.93	10.85	17.63	16.63	51.79	23	14.59	15.74	24.28	52.8	20.38	16.25	10.83
Price/Free Cash Flow Average	11.68	10.97	20.2	12.19	21.56	20.45	61.1	29.38	16.96	20.53	25.42	48.82	21.61	13.98	11.09
Price/Free Cash Flow High	13.74	12.6	21.64	13.53	23.89	25.35	76.21	36.54	20.42	28.2	31.32	72.57	28	16.99	14.78
Price/Free Cash Flow Low	9.09	9.77	18.06	10.36	17.64	16.73	50.61	23.3	12.15	13.45	20.5	33.25	14.37	11.48	8.36
EV/Sales Average	1.54	1.54	1.64	1.62	1.98	2.11	3.04	3.62	4.03	5.35	6.81	5.72	4.67	3.85	3.29
EV/Sales High	1.79	1.74	1.75	1.79	2.19	2.62	3.78	4.5	4.86	7.41	8.41	8.34	5.95	4.61	4.28
EV/Sales Low	1.21	1.38	1.47	1.37	1.61	1.73	2.52	2.87	2.89	3.45	5.48	4	3.24	3.23	2.56
EV/EBITDA Average	7.48	8.05	11.05	11.72	13.37	16.75	23.48	25.33	25.61	24.32	31.21	26.17	25.82	23.52	22.14
EV/EBITDA High	8.72	9.15	11.81	12.99	14.82	20.78	29.25	31.49	30.85	33.69	38.55	38.14	32.85	28.13	28.76
EV/EBITDA Low	5.9	7.25	9.91	9.97	10.92	13.69	19.48	20.09	18.34	15.67	25.1	18.32	17.87	19.69	17.24
EV/EBIT Average	10.44	12.03	20.64	23.42	23.94	37.02	50.19	43.81	40.57	32.33	39.8	33.73	36.97	36.77	38.88
EV/EBIT High	12.18	13.66	22.08	25.98	26.54	45.94	62.5	54.48	48.87	44.77	49.15	49.16	47.03	43.99	50.52
EV/EBIT Low	8.24	10.83	18.52	19.93	19.56	30.26	41.64	34.75	29.05	20.82	32	23.61	25.58	30.79	30.29
Last Price	96.04	105.05	123.61	120.56	138.66	182.28	238.67	232.22	370.03	582.94	755.57	420.49	322.89	328.51	302.99
High Price	126.98	118	127.17	134.13	152.38	184.89	273.87	345.15	376.43	648.39	832.7	752.17	509.62	387.99	373.69
Enterprise Value Average	3,187	3,177	3,498	3,513	3,990	4,370	6,563	8,288	9,318	13,619	19,913	16,025	12,488	9,892	8,500
Enterprise Value High	3,718	3,610	3,741	3,896	4,424	5,421	8,173	10,306	11,224	18,865	24,593	23,357	15,887	11,833	11,044
Enterprise Value Low	2,514	2,860	3,139	2,989	3,260	3,571	5,445	6,573	6,672	8,773	16,010	11,219	8,642	8,282	6,621

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	28	28	29	29	29	30	30	30	30	30	30	30	29	28	27
Diluted Weighted Avg Shares	28	29	29	29	29	30	30	30	30	30	30	30	29	28	27
Basic Weighted Avg Shares	28	28	29	29	29	29	30	30	30	30	30	30	29	28	27
Revenue per Share	73.97	73.14	74.61	75.32	69.19	70.25	72.84	76.73	77.46	85.52	97.97	94.08	91.45	90.97	94.75
EBITDA per Share	15.21	13.95	11.08	10.39	10.23	8.86	9.42	10.97	12.19	18.81	21.39	20.56	16.56	14.91	14.09
Operating Income per Share	10.89	9.34	5.93	5.19	5.71	4.01	4.41	6.34	7.7	14.15	16.77	15.95	11.56	9.53	8.02
Basic EPS, GAAP	6.39	5.85	2.72	3.08	3.74	0.88	4.12	12.25	58.93	128.13	142.61	-121.79	-21.82	-65.36	27.87
Basic EPS from Cont Ops	6.38	5.85	2.72	3.08	3.74	0.88	4.12	12.25	58.93	128.13	142.61	-121.79	-21.82	-65.36	27.87
Diluted EPS, GAAP	6.29	5.78	2.69	3.05	3.71	0.88	4.07	12.1	58.27	126.47	140.83	-121.79	-21.82	-65.36	27.85
Diluted EPS from Cont Ops	6.28	5.78	2.69	3.05	3.71	0.88	4.07	12.1	58.27	126.47	140.83	-121.79	-21.82	-65.36	27.85
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	9.37	9.42	5.92	9.47	6.38	7.34	3.51	9.57	15.34	19.65	22.44	6.53	12.84	16.13	19.52
Free Cash Flow per Basic Share	9.36	9.36	5.89	8.93	6.33	7.33	3.38	9.57	12.04	16	17.96	2.69	7.47	9.44	13.74
Cash & Equivalents per Share	29.01	32.56	21.3	24.16	26.94	28.51	25.46	28.31	37.35	33.29	29.16	60.12	55.02	59	56.51
Book Value per Share	48.51	54.02	56.19	58.7	61.95	62.11	61.72	124.75	183.32	311.34	453.4	332.32	317.05	262.86	299.9
Tangible Book Value per Share	36.24	44.51	49.07	49.54	61.01	65.91	75.87	122.92	179.12	315.39	438.61	298.02	274.13	207.88	245.74

Bio-Rad Laboratories, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)